Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.318,08
-1,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kiromic BioPharma Inc (KRBP) Kiromic BioPharma Inc (KRBP) Notizie

Kiromic BioPharma Inc

KRBP
0,60
0,00 (0,00%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202414:08BWKiromic BioPharma Reports Consistent Favorable Safety,..
19/4/202422:30EDGAR2Form 8-K - Current report
10/4/202422:30EDGAR2Form RW - Registration Withdrawal Request
05/4/202422:30EDGAR2Form 8-K - Current report
02/4/202422:30EDGAR2Form 8-K - Current report
02/4/202414:18BWKiromic BioPharma Reports Favorable Safety, Tolerability,..
21/3/202422:21EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20/3/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/3/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/3/202413:08BWEarly Efficacy Results Show Primary Lung Tumor Stabilization..
01/3/202414:08BWKiromic BioPharma Adds Virginia Oncology Associates, PC as..
29/2/202400:30BWKiromic BioPharma to Present at the OTC Markets’ Virtual..
28/2/202422:09GLOBEKiromic BioPharma to Present at the OTC Markets’ Virtual..
14/2/202422:30EDGAR2Form 8-K - Current report
14/2/202414:08BWResults from First Patient in Kiromic BioPharma’s..
29/1/202413:47BWKiromic BioPharma Reports Favorable Early Efficacy Results..
11/1/202422:15EDGAR2Form 8-K - Current report
05/1/202414:08BWKiromic BioPharma Reports Favorable Early Safety and..
14/12/202314:17BW Kiromic BioPharma Announces First Patient Dosed in Phase 1..
09/11/202315:49EDGAR2Form 8-K - Current report
13/9/202322:45EDGAR2Form 8-K - Current report
13/9/202322:35BWKiromic BioPharma Common Stock to Begin Trading on the OTC..
29/8/202322:15EDGAR2Form 8-K - Current report
15/8/202322:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/8/202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202318:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/7/202322:50EDGAR2Form 8-K - Current report
25/7/202322:28EDGAR2Form 8-K - Current report
24/7/202321:53EDGAR2Form 8-K - Current report
24/7/202321:00BWKiromic BioPharma Welcomes Two New Directors to its Board
19/7/202322:15EDGAR2Form 8-K - Current report
18/7/202322:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/7/202322:21EDGAR2Form 8-K - Current report
29/6/202322:33EDGAR2Form S-1 - General form for registration of securities under..
Apertura: Min: Max:
Chiusura: 0,60

La tua Cronologia

NASDAQ
KRBP
Kiromic BioPharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network